ZEB2 and non-small cell lung carcinoma: In addition, miR-342-3p overexpression-mediated anti-tumor effects in NSCLC cells were largely reversed by the accumulation of ZEB2, suggesting that miR-342-3p restrained NSCLC progression largely by downregulating ZEB2 expression in vitro.